PaxVax

Mar 25, 2020

Outlook into the Worldwide Oral Vaccine Market to 2025 - Featuring GlaxoSmithKline, PaxVax and Shanghai BravoBio Among Others

Mar 05, 2020

World Vaccines Market Outlook to 2030: Major Players are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck and Pfizer

Nov 06, 2019

Vaccines Market Size Worth US$ 55.2 Bn by 2026 | CAGR 6.4%

Jul 12, 2019

Global Cholera Vaccines Market Outlook to 2024 - AstraZeneca, Shantha Biotechnics, Valneva, Merck & Co, and PaxVax are Leading the Competition

Apr 02, 2019

The global cholera vaccine market generated $65 million in 2017, and is projected to reach $207 million by 2025, growing at a CAGR of 15.6% from 2018 to 2025

Mar 04, 2019

Cholera Vaccine Market to Reach $207 Mn, Globally, by 2025 at 15.6% CAGR: Allied Market Research

Aug 09, 2018

Emergent BioSolutions to Acquire PaxVax from Cerberus Capital Management

Apr 25, 2018

PaxVax Announces the Initiation of Phase 2b Trial for its Chikungunya Vaccine

Dec 06, 2017

Randomized Placebo-Controlled Study Provides Encouraging Results for a Higher Dose Formulation of Vaxchora® (CVD 103-HgR) as a Potential Tool in Containing Cholera Epidemics